U.S. markets open in 7 hours 29 minutes

S&P Futures
4,232.50
+7.25(+0.17%)
Dow Futures
34,776.00
+90.00(+0.26%)
Nasdaq Futures
13,718.00
+8.25(+0.06%)

Ultragenyx Pharmaceutical Inc. (RARE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

114.53-1.18 (-1.02%)

At close: 4:00PM EDT

Currency in USD

Earnings Estimate	Current Qtr. (Jun 2021)	Next Qtr. (Sep 2021)	Current Year (2021)	Next Year (2022)
No. of Analysts	13	13	13	15
Avg. Estimate	-1.25	-1.36	-6.08	-5.21
Low Estimate	-1.8	-2.12	-8.16	-7.75
High Estimate	-0.82	-0.88	-3.42	-2.99
Year Ago EPS	0.41	-1.13	-3.07	-6.08

Revenue Estimate	Current Qtr. (Jun 2021)	Next Qtr. (Sep 2021)	Current Year (2021)	Next Year (2022)
No. of Analysts	10	10	13	14
Avg. Estimate	84.31M	79.78M	334.88M	405.9M
Low Estimate	74M	74M	216M	324.3M
High Estimate	91.7M	87.8M	372.02M	504.25M
Year Ago Sales	61.71M	81.47M	271.03M	334.88M
Sales Growth (year/est)	36.60%	-2.10%	23.60%	21.20%

Earnings History	6/29/2020	9/29/2020	12/30/2020	3/30/2021
EPS Est.	-1.54	-1.26	-1.15	-1.24
EPS Actual	0.41	-1.13	-0.37	-2.03
Difference	1.95	0.13	0.78	-0.79
Surprise %	126.60%	10.30%	67.80%	-63.70%

EPS Trend	Current Qtr. (Jun 2021)	Next Qtr. (Sep 2021)	Current Year (2021)	Next Year (2022)
Current Estimate	-1.25	-1.36	-6.08	-5.21
7 Days Ago	-1.3	-1.33	-5.26	-4.53
30 Days Ago	-1.26	-1.27	-5	-4.24
60 Days Ago	-1.29	-1.3	-5.12	-4.29
90 Days Ago	-1.15	-1.12	-4.09	-3.1

EPS Revisions	Current Qtr. (Jun 2021)	Next Qtr. (Sep 2021)	Current Year (2021)	Next Year (2022)
Up Last 7 Days	N/A	N/A	N/A	N/A
Up Last 30 Days	6	5	1	1
Down Last 7 Days	N/A	N/A	N/A	N/A
Down Last 30 Days	N/A	N/A	N/A	N/A

Growth Estimates	RARE	Industry	Sector(s)	S&P 500
Current Qtr.	-404.90%	N/A	N/A	N/A
Next Qtr.	-20.40%	N/A	N/A	N/A
Current Year	-98.00%	N/A	N/A	N/A
Next Year	14.30%	N/A	N/A	N/A
Next 5 Years (per annum)	17.20%	N/A	N/A	N/A
Past 5 Years (per annum)	N/A	N/A	N/A	N/A